Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2013 (Vol. 33, No. 1)

Twisting and Turning for Better Protein Expression

  • The manufacture of protein therapeutics is only as efficient as the expression system. Despite the emergence of several platform approaches (e.g., CHO for monoclonal antibodies), drug developers are constantly tweaking cells and microorganisms to optimize productivity and product quality. One focus of CHI’s upcoming “Peptalk” will be expression, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.